Report: How MA Plan Design Affects Utilization, Health Equity
A new study found that enrollees with zero-premium MA plans are three times as likely to be non-White compared to other MA enrollees and traditional Medicare enrollees.
Report: MA Members Have Better Quality Outcomes than FFS Members
Medicare Advantage members have fewer readmissions, fewer preventable hospitalizations and lower rates of high-risk medication use than traditional Medicare, new research by Harvard Medical School and Inovalon shows.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Study: MA Beneficiaries Have Lower Utilization Than Traditional Medicare
A new study found that MA beneficiaries have more than 50% fewer inpatient stays and 22% fewer emergency department visits than traditional Medicare enrollees.
Investors to take Inovalon private in $7.3B deal
A consortium of investors, led by Nordic Capital and Insight Partners, plan to acquire the company in a deal that would value it at $7.3 billion. It’s expected to close later this year or in early 2022.